Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT05201118
Status:
UNKNOWN
Last Update Posted:
2022-05-24
First Post:
2022-01-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
Sponsor:
Chunrui Li
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-05
First Submit QC Date:
None
Study First Post Date:
2022-01-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-17
Last Update Post Date:
2022-05-24
Last Update Post Date Type:
ACTUAL